（图片来源：摄图网） 据媒体报道，近日，国家乳业技术创新中心技术研发团队成功研制出具有完全自主知识产权的奶牛种用胚胎 基因组遗传评估芯片和"高产、抗病、长生产期"功能强化基因组预测芯片。填补了我国基因芯片检测遗传评 估技术的空白，标志着中国在奶牛育种领域实现了从"跟跑"到"并跑"乃至"领跑"的关键跨越。 基因芯片是一种基于微阵列技术的高通量生物信息分析工具，能够快速检测与奶牛生产性能相关的关键功能 基因信息。此前，该技术长期被欧美发达国家垄断，国内奶牛育种依赖进口芯片，成本高昂且技术受限。此 次研发的系列基因芯片通过集成机器学习与算法模型，依托全国96座规模化牧场、60余万头奶牛的育种大数 据平台，成功解析了世界优良奶牛品种与中国区域牛群的遗传指纹，实现了从"数据积累"到"技术反超"的跨 越。 与传统全基因组测序相比，新芯片的检测效率提升4倍以上，成本仅为其1/5，而且，能够高效检测与奶牛生 产性能相关的关键功能基因信息，确保经芯片检测的奶牛能生产出"高蛋白、优脂肪、低体细胞数、低菌落 总数"的优质牛奶。不仅降低了育种成本，更通过"芯片+大数据"的闭环优化，为培育本土化高产奶牛新品系 提供了技术支撑。 基因芯 ...

近日，由中红医疗及旗下桂林恒保共同参与修订的强制性国家标准GB24788-2025《医用手套安全技术 要求》正式发布，这一标准将于2028年6月1日起正式实施。作为我国医用手套领域的重要技术规范，新 标准整合并升级了原有分散的技术要求，在修订《医用手套表面残余粉末、水抽提蛋白质限量》的基础 上，吸纳了一次性灭菌橡胶外科手套、医用橡胶检查手套及聚氯乙烯医用检查手套的三项核心安全规 范，形成了覆盖"防过敏、降感染、控粉尘、限残留"的四重安全体系。 一、国家标准发布：行业规范化进程的里程碑 具体而言，新标准明确规定了四大核心安全指标： 1.水抽提蛋白质限量：通过严格控制可能引发过敏反应的蛋白质残留，显著降低医护人员和患者的过敏 风险； 2.微生物指标：强化对细菌、病毒等病原体的消杀要求，从源头阻断感染传播链条； 3.表面残余粉末限量：减少滑石粉等可能引发呼吸道刺激或组织炎症的物质残留，提升使用安全性； 国际化布局与质量认证 中红医疗产品已通过美国FDA认证、欧盟CE认证、ISO14001环境管理体系认证等多项国际权威资质， 其医用手套符合欧盟最新标准EN455，涵盖水渗透测试、物理性能、生物学评价等全流程检测要求。 ...

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Wuzhong*) is facing potential forced delisting due to continuous financial fraud over four years, with the China Securities Regulatory Commission (CSRC) proposing a fine of 10 million yuan and indicating a "zero tolerance" stance towards such violations [1][5]. Group 1: Financial Misconduct - *ST Wuzhong* has been found to have falsified financial reports from 2020 to 2023, inflating revenue by 4.95 billion yuan, 4.69 billion yuan, 4.31 billion yuan, and 3.77 billion yuan, which accounted for 26.46%, 26.39%, 21.26%, and 16.82% of the reported revenue for those years respectively [2]. - The company also inflated total profits by 14.58 million yuan, 20.27 million yuan, 19.92 million yuan, and 21.22 million yuan, representing 2.89%, 51.65%, 26.42%, and 29.81% of the total profits for the respective years [2]. - Additionally, *ST Wuzhong* failed to disclose significant non-operating fund occupation by related parties, with amounts reaching 1.27 billion yuan, 1.39 billion yuan, 1.54 billion yuan, and 1.69 billion yuan from 2020 to 2023, which constituted 6.88%, 74.2%, 84.6%, and 96.09% of the net assets for those years [2]. Group 2: Regulatory Actions - The CSRC plans to impose a total fine of 30.5 million yuan on *ST Wuzhong* and its responsible individuals, with the actual controller, Qian Qunshan, facing a proposed 10-year ban from the securities market due to severe misconduct [3]. - Starting July 14, *ST Wuzhong*'s stock will be subject to delisting risk warnings due to its financial fraud, which has already led to previous warnings and a lack of opinion from the auditing firm on its 2024 financial report [4]. - The company has expressed its intention to cooperate with the CSRC and will exercise its rights to defend against the proposed penalties [4].

Core Viewpoint - *ST Suwu has been found guilty of multiple violations, including falsifying financial statements and failing to disclose the actual controlling shareholder, leading to a proposed fine of 10 million yuan and potential delisting from the stock exchange [1][6]. Summary by Sections Violations Identified - The company failed to disclose the actual controlling shareholder, with false records in annual reports from 2018 to 2023, incorrectly naming Qian Qunying as the actual controller instead of Qian Qunshan [2]. - *ST Suwu inflated revenue, costs, and profits through non-commercial trade activities with related companies, resulting in inflated revenues of 495 million yuan, 468 million yuan, 431 million yuan, and 377 million yuan for the years 2020 to 2023, which accounted for 26.46%, 26.39%, 21.26%, and 16.82% of reported revenues respectively [3]. - The company also failed to disclose significant non-operating fund occupations by related parties, with balances of 127 million yuan, 1.393 billion yuan, 1.543 billion yuan, and 1.693 billion yuan from 2020 to 2023, representing 6.88%, 74.2%, 84.6%, and 96.09% of net assets respectively [5]. Proposed Penalties - The China Securities Regulatory Commission (CSRC) proposed a fine of 10 million yuan for *ST Suwu and a 10-year market ban for Qian Qunshan, the actual controller and chairman [6][7]. - Additional fines were proposed for other board members, including 15 million yuan for Qian Qunshan, 2 million yuan for Qian Qunying, and 1.5 million yuan for Chen Yi [7]. Company Status - As of July 11, *ST Suwu's stock price was 2.42 yuan per share, with a total market capitalization of 1.723 billion yuan [10]. - The company has stated it will cooperate with the CSRC and exercise its rights to defend against the proposed penalties [9].

Core Viewpoint - *ST Suwu has received an administrative penalty notice from the China Securities Regulatory Commission (CSRC), indicating that the company may face major illegal delisting due to inflated revenue, costs, and profits in its annual reports from 2020 to 2023 [2][5][7]. Summary by Relevant Sections Administrative Penalty Notice - The notice states that *ST Suwu's subsidiaries engaged in non-commercial trade activities with related companies, leading to inflated financial figures [5][7]. - The company is at risk of being delisted under the Shanghai Stock Exchange's rules due to these violations [2][10]. Financial Impact - The inflated revenue figures from 2020 to 2023 were reported as follows: - 2020: 495 million yuan (26.46%) - 2021: 469 million yuan (26.39%) - 2022: 431 million yuan (21.26%) - 2023: 377 million yuan (16.82%) [7]. - The inflated costs were: - 2020: 481 million yuan (37.08%) - 2021: 448 million yuan (35.47%) - 2022: 411 million yuan (28.40%) - 2023: 355 million yuan (20.95%) [7]. - The inflated profit figures were: - 2020: 14.58 million yuan (2.89%) - 2021: 20.27 million yuan (51.65%) - 2022: 19.92 million yuan (26.42%) - 2023: 21.22 million yuan (29.81%) [7]. Company Response and Future Actions - *ST Suwu has issued its first risk warning regarding the potential for major illegal delisting [8]. - If the company receives a formal penalty decision confirming the violations, it will apply for a trading suspension and disclose relevant information [10]. - The Shanghai Stock Exchange will issue a notice regarding the potential termination of *ST Suwu's stock listing within five trading days of the suspension [10]. Recent Financial Performance - For the year 2024, *ST Suwu reported: - Revenue of 1.599 billion yuan, a decrease of 28.64% year-on-year - Net profit attributable to shareholders of 70.48 million yuan, compared to a loss of 71.95 million yuan in 2023 [10][11].

Core Viewpoint - *ST Suwu has received an administrative penalty notice from the China Securities Regulatory Commission (CSRC), indicating that the company has inflated its operating income, operating costs, and profits from 2020 to 2023, which may lead to a forced delisting due to significant violations [2][10]. Summary by Sections Administrative Penalty Notice - On July 13, *ST Suwu announced it received an administrative penalty notice from the CSRC, which identified false records in its annual reports from 2020 to 2023 [2][10]. - The notice states that *ST Suwu's subsidiaries engaged in non-commercial trade activities with related companies, resulting in inflated financial figures [7]. Financial Impact - The inflated operating income for the years 2020 to 2023 was reported as follows: 4.95 billion, 4.69 billion, 4.31 billion, and 3.77 billion, representing 26.46%, 26.39%, 21.26%, and 16.82% of the reported operating income for those years, respectively [9]. - The inflated operating costs for the same years were 4.81 billion, 4.48 billion, 4.11 billion, and 3.55 billion, accounting for 37.08%, 35.47%, 28.40%, and 20.95% of the reported operating costs [9]. - The inflated total profits were 14.58 million, 20.27 million, 19.92 million, and 21.22 million, which constituted 2.89%, 51.65%, 26.42%, and 29.81% of the reported total profits for those years [10]. Regulatory Actions - The CSRC plans to impose a fine of 10 million yuan on *ST Suwu and a total of 20.5 million yuan in fines on its executives [10]. - The company has issued its first risk warning announcement regarding the potential for forced delisting due to significant violations [11][12]. Future Implications - If *ST Suwu receives a formal administrative penalty decision indicating significant violations, it will apply for a trading suspension and disclose relevant information promptly [14]. - The Shanghai Stock Exchange will issue a notice regarding the potential termination of *ST Suwu's listing within five trading days of the suspension [14]. Recent Financial Performance - In 2024, *ST Suwu reported an operating income of 1.599 billion, a year-on-year decrease of 28.64%, with a net profit attributable to shareholders of 70.48 million, compared to a net loss of 71.95 million in 2023 [15].

Core Viewpoint - The Jingmen Chemical Circular Industry Park is advancing its "oil-to-special" project, marking a new phase in the optimization and upgrading of the petrochemical industry, which is crucial for regional economic development [1] Group 1: Industry Development - The petrochemical industry is a pillar of the Jingmen Chemical Circular Industry Park, which has successfully attracted 28 downstream enterprises, creating a complete industrial ecosystem from basic raw materials to high-end new materials [2] - The park has implemented a "one enterprise, one policy" approach to optimize land use, reviving six inefficient enterprises and freeing up hundreds of acres for new projects [2] - The park is focusing on technological innovation and supporting enterprises in applying for provincial-level technical transformation projects to upgrade production processes [2] Group 2: Industrial Chain Collaboration - The park is enhancing industrial chain collaboration by attracting Fortune 500 and specialized projects, effectively connecting upstream and downstream enterprises within the carbon one industrial chain [3] - The lithium battery materials industry chain is thriving, with a complete lifecycle resource recycling model established, expected to generate a total output value of 20 billion yuan upon full production [3] - The park has achieved a virtuous cycle of "large projects driving the gathering of supporting enterprises and the development of industrial clusters" [3] Group 3: Quality and Precision in Development - The park emphasizes high-quality development by providing tailored solutions for enterprises facing labor shortages and financing difficulties, fostering collaboration among enterprises [4] - Significant investments are being made in key industries, such as a 1.5 billion yuan expansion of a photoinitiator project, which is expected to add 3.5 billion yuan in output value [4] Group 4: Niche Market Focus - The park adopts a "small but refined" approach, particularly in the waterproof materials industry, where it has attracted leading companies to form a specialized industrial chain expected to exceed 2 billion yuan in total output value [5] Group 5: Talent Development - The park prioritizes talent development by establishing a chemical safety skills training base and forming a talent alliance to integrate resources from universities and leading enterprises [6] - The collaboration with Wuhan University of Engineering aims to create a seamless connection between talent training and industry needs, enhancing the innovation vitality of the biopharmaceutical industry chain [6] - The biopharmaceutical sector has expanded its product matrix to cover 324 varieties across six categories, becoming a key driver of regional economic growth [6]

Core Insights - The antibacterial paint market in China is experiencing rapid growth due to increasing health awareness and demand for hygiene products, with the market size projected to reach approximately 10.98 billion yuan in 2024 and 15.368 billion yuan by 2027 [1][16] - The industry is benefiting from various national policies such as new infrastructure projects, urbanization, and rural revitalization, which are expected to drive demand for coatings [1][16] - Antibacterial coatings not only improve indoor air quality and reduce infection risks but also enhance the durability of painted surfaces, making them popular in medical institutions, homes, and public spaces [1][16] Antibacterial Coatings Industry Overview - Antibacterial coatings are designed to prevent the growth of bacteria, fungi, and algae, offering superior disinfection effects compared to regular paints [3][5] - The market is segmented into natural, organic, and inorganic antibacterial coatings, each with distinct properties and applications [3] Industry Development History - The antibacterial industry in China began in the 1980s and gained momentum in the late 1990s, with significant contributions from companies like Nippon Paint [8] - The establishment of standards for antibacterial coatings by the China Coatings Industry Association in 2020 has further propelled the industry's growth [8] Industry Chain - The upstream of the antibacterial coatings industry includes raw materials such as antibacterial agents, film-forming agents, and solvents, while the downstream applications span construction, food processing, healthcare, and more [10][12] Market Trends - The antibacterial agent market is projected to reach approximately 13.01 billion yuan in 2024, with a year-on-year growth of 6.71%, driven by expanding application scenarios and technological innovations [12] - The construction industry is a key application area for antibacterial coatings, with the total output value of the construction industry in China expected to grow from 21.39 trillion yuan in 2017 to 32.65 trillion yuan by 2024, reflecting a compound annual growth rate of 6.23% [13] Competitive Landscape - Leading international companies in the antibacterial coatings market include AkzoNobel, PPG Industries, Sherwin-Williams, and BASF, while domestic leaders include companies like Three Trees, Nippon Paint China, and Carpoly [18][20] - The competitive landscape is evolving, with a focus on technological innovation and the development of high-end applications in healthcare and home appliances [18] Future Development Trends - The industry is expected to focus on the development of composite antibacterial coatings that optimize the synergistic effects of different antibacterial agents [25] - The application of inorganic nano antibacterial materials is anticipated to deepen, with a focus on improving dispersion and stability in coatings [26][27] - Research into the mechanisms of antibacterial agents will support the development of targeted products, alongside the establishment of comprehensive testing methods and industry standards [28]

Core Viewpoint - Yabao Chemical has been upgraded from a BBB to an AA ESG rating, the highest in the industry, reflecting its leadership in green transformation and sustainable development [1] Group 1: ESG Initiatives - Yabao Chemical actively responds to the Science Based Targets initiative (SBTi) and aims for a 1.5°C temperature control target, committing to the long-term vision of the Paris Agreement [1] - The company has set clear emission reduction targets based on 2022 levels for Scope 1, Scope 2, and Scope 3 emissions, with plans to achieve these by 2033 [1] - Yabao Chemical successfully passed the SBTi's rigorous target verification in June 2025, marking a significant milestone in its commitment to global climate governance [1] Group 2: Technological Innovation - Yabao Chemical is increasing its R&D investment, with a projected R&D expenditure of 123 million yuan in 2024, establishing an innovation system covering the entire product lifecycle [2] - The company has made breakthroughs in its subsidiary Nantong Yabao's diazotization technology, improving reaction efficiency and addressing issues in traditional processes [2] - The company’s antiviral drug pilot project has commenced operations at the Lanzhou pilot base, enhancing its market competitiveness in antiviral drug development [2] Group 3: Social Responsibility and Talent Development - Yabao Chemical has established harmonious labor relations and respects employee rights, with all major production bases certified under ISO 45001 for occupational health and safety management [3] - The company has invested over 10 million yuan in safety management training projects to create a safer and more efficient working environment [3] - Yabao Chemical promotes employee development through diverse training programs and career advancement systems, fostering employee engagement and creativity [3] Group 4: Future Commitment - Yabao Chemical will continue to uphold its development philosophy of green, innovation, efficiency, and reliability, deepening ESG strategic practices [4] - The company aims to collaborate with various sectors to explore paths for green growth and inclusive high-quality development, contributing to global sustainable development goals [4]

6月27日，国家农业图书馆内，一场主题为"农业生物安全——青年与未来"的学术交流活动正在进行。 台上，27名青年科学家依次登台，围绕合成生物、基因编辑、生物育种等农业前沿技术分享思考；台 下，多位知名院士专家轮流点评。这场学术交流活动，是中国农业科学院青年人才联合会成立大会的一 部分。近年来，中国农科院实行"青年英才""青创专项""青年引航"等"青10条"人才培育措施，建立了青 年人才的链式培养机制。 今年3月，中国农科院植物保护研究所宁约瑟研究员团队水稻研究再获突破。团队通过分子设计育种和 基因编辑技术的有效结合，在水稻中创制出对稻瘟病和白叶枯病具有广谱抗病且不影响生长的优异新材 料。"'青年英才'的稳定支持，为我们解决了后顾之忧。团队能够安心长期探索，是成果不断涌现的关 键。"宁约瑟说。 如何发挥青年人才联合会的作用，助力青年人才成长？一方面，强化"硬支撑"。中国农科院打破常规， 优化各类资源配置机制。比如，中国农科院重大任务、战略咨询任务，优先支持联合会多主体协同的跨 学科创新项目、软硬结合的战略咨询项目。此外，对探索性强、风险高的交叉研究给予更长的研究周期 和更大的包容度。 《 人民日报 》（ 202 ...